Catalyst Wire Dossier Catalyst Wire Dossier

EVM14

· Everest Medicines (Beijing) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EVM14, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors [Phase 1, Phase 2]

See pricing